Skip to main content

Arvinas Selects Certara’s D360 to Advance Speed and Efficiency of Discovery Research

Drug discovery scientists often waste time managing data instead of finding promising compounds. The right technology streamlines this process, leading to a more efficient DMTA (Design, Make, Test, Analyze) cycle. Without an integrated informatics platform, scientists face significant bottlenecks, hindering productivity and innovation. Arvinas, a leading biopharmaceutical company, struggled with data management issues that impacted their drug discovery efforts. Learn how Arvinas leveraged D360 to transform their data management practices, reduce time-to-insight, enhance decision-making, and accelerate progression through the DMTA cycle in our case study. Discover the specific benefits and the significant difference the right informatics platform can make in drug discovery.

"*" indicates required fields

Subscribe
Please find the Certara privacy policy here. You can unsubscribe, and withdraw your consent, at any time.
This field is for validation purposes and should be left unchanged.